When Knowledge Drives Results: The Impact of a Winning Data Strategy

Posted by Cytel

Oct 10, 2018 12:31:00 PM

datastrategy

Convincing regulators to approve drugs has never been easy, with billions of dollars spent each year to generate the clinical evidence required to clear the multiple safety and effectiveness hurdles. Many people have hailed the era of big data as a turning point for pharma, with the latest technology allowing for an increasingly granular and detailed readout of a drug’s performance in clinical trials. But with great insights comes great quantities of data and managing the vast amount of information generated by a study can be difficult.

In a recent interview with  Pharmaphorum, Cytel's Executive Director of Data Management Paul Fardy discussed the importance of establishing a clinical data strategy, an element of planning that is all too frequently decided too late in development - putting the investment in the trial at risk. 

In the article, Paul explained the changes that needed to be made to the way sponsors think about their clinical data, by defining what data is being collected and the kind of standards that must be applied as early as possible.

Click the button below to instantly access the full article.

read article

 Further reading

Blog: What makes a good data manager?

Blog: Adaptive Designs from a data management perspectives

Topics: CDISC, SDTM, Data Management, clinical data management

The Cytel blog keeps you up to speed with the latest developments in biostatistics and clinical biometrics.  Sign up for updates direct to your inbox. You can unsubscribe at any time.

 

Posts by Topic

see all

Recent Posts